small molecule

ULESFIA

BENZYL ALCOHOL

Loss of exclusivity—loss of exclusivity

CompanyShionogi →See this company's full patent-cliff portfolio

Drug detail

Brand name	ULESFIA
Active ingredient	BENZYL ALCOHOL
Strength	5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	LOTION
Route	TOPICAL
Modality	Small molecule
FDA approval	April 2009
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.